CGB 0.00% 2.1¢ cann global limited

canntab therapeutics news, page-4

  1. 218 Posts.
    lightbulb Created with Sketch. 54
    "There is currently no pharmaceutical-grade cannabis medicine yet available for doctors to prescribe anywhere in the world, however high-THC smoked marijuana is available in countries with health department exemptions including the United States, Canada and Israel.

    VitaCann believes the new product could be a market disruptor.

    "It is our belief that these new pharmaceutical-grade Canntab products however will, subject to the formal approval process, achieve the approvals required under the current legislation to be the premier medical cannabis product that can be confidently recommended and prescribed by the medical fraternities in Australia and globally," said the company."

    https://www.businessnewsaus.com.au/...to-develop--game-changing--cannabis-pill.html
 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.